The list of medicinal products intended for the treatment of rare diseases requiring specific treatment has been expanded.
According to Modern.az, Minister of Health Teymur Musayev has signed a relevant decision in this regard.
According to the decision, the following medicinal products have also been added to the list:
|
128. |
Trikafta / Trikafta |
Elexacaftor/ tezacaftor/ ivacaftor + ivacaftor |
Vertex Pharmaceuticals |
|
129. |
Kalideko / Kalydeco |
Ivacaftor |
Vertex Pharmaceuticals |
|
130. |
Orencia / Orencia |
Abatacept |
Bristol-Myers Squibb |
|
131 |
Livmarli / Livmarli |
Maralixibat |
Mirum Pharmaceuticals International |
